Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Lamotrigine Patent Expiration

Lamotrigine was first introduced by Glaxosmithkline Llc in its drug Lamictal on Dec 27, 1994. Other drugs containing Lamotrigine are Lamictal Xr, Lamictal Cd, Lamictal Odt. 41 different companies have introduced drugs containing Lamotrigine.


Lamotrigine Patents

Given below is the list of patents protecting Lamotrigine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lamictal Odt US7919115 Orally disintegrating tablet compositions of lamotrigine Jan 04, 2029 Glaxosmithkline Llc
Lamictal Odt US8840925 Orally disintegrating tablet compositions of lamotrigine Jul 02, 2028 Glaxosmithkline Llc
Lamictal Odt US9339504 Orally disintegrating tablet compositions of lamotrigine Jul 02, 2028 Glaxosmithkline Llc
Lamictal Xr US8637512 Formulations and method of treatment Jun 14, 2028 Glaxosmithkline Llc
Lamictal Xr US9144547 Oral dosage form for controlled drug release Sep 22, 2023

(Expired)

 Glaxosmithkline Llc
Lamictal Cd US5698226

(Pediatric)

 Water-dispersible tablets Jul 29, 2012

(Expired)

 Glaxosmithkline Llc



Lamotrigine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lamotrigine Generic API Manufacturers

Several generic applications have been filed for Lamotrigine. The first generic version for Lamotrigine was by Teva Pharmaceuticals Usa Inc and was approved on Jun 21, 2006. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Oct 1, 2024.

Given below is the list of companies who have filed for Lamotrigine generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, extended release Prescription ORAL AB Oct 17, 2013
50MG

tablet, extended release Prescription ORAL AB Oct 17, 2013
100MG

tablet, extended release Prescription ORAL AB Oct 17, 2013
200MG

tablet, extended release Prescription ORAL AB Oct 17, 2013
300MG

tablet, extended release Prescription ORAL AB Oct 17, 2013
250MG

tablet, extended release Prescription ORAL AB Nov 13, 2013


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





2. ACTAVIS TOTOWA

Actavis Totowa Llc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Actavis Totowa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Apr 8, 2011
200MG

tablet Discontinued ORAL N/A Apr 8, 2011
150MG

tablet Discontinued ORAL N/A Apr 8, 2011
100MG

tablet Discontinued ORAL N/A Apr 8, 2011


Manufacturing Plant Locations
New

Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.

Country City Firm Name
United States
Little Falls Actavis Totowa LLC
Totowa Actavis Totowa LLC





3. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Jan 27, 2009
100MG

tablet Discontinued ORAL N/A Jan 27, 2009
150MG

tablet Discontinued ORAL N/A Jan 27, 2009
200MG

tablet Discontinued ORAL N/A Jan 27, 2009





4. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021
50MG

tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021
25MG

tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021
200MG

tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





5. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, for suspension Prescription ORAL AB Jun 12, 2014
5MG

tablet, for suspension Prescription ORAL AB Jun 12, 2014
250MG

tablet, extended release Prescription ORAL AB Oct 1, 2024
200MG

tablet, extended release Prescription ORAL AB Oct 1, 2024
300MG

tablet, extended release Prescription ORAL AB Oct 1, 2024


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Vadodara Alembic Pharmaceuticals, Ltd
Panchmahal Alembic Pharmaceuticals Limited
Panelav Alembic Pharmaceuticals Limited





6. ALEMBIC PHARMS LTD

Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Jan 13, 2011
200MG

tablet Prescription ORAL AB Jan 13, 2011
25MG

tablet Prescription ORAL AB Jan 13, 2011
150MG

tablet Prescription ORAL AB Jan 13, 2011





7. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Jun 14, 2013
150MG

tablet Prescription ORAL AB Jun 14, 2013
100MG

tablet Prescription ORAL AB Jun 14, 2013
25MG

tablet Prescription ORAL AB Jun 14, 2013





8. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet, extended release Prescription ORAL AB Nov 30, 2018
50MG

tablet, extended release Prescription ORAL AB Nov 30, 2018
250MG

tablet, extended release Prescription ORAL AB Nov 30, 2018
100MG

tablet, extended release Prescription ORAL AB Nov 30, 2018
25MG

tablet, extended release Prescription ORAL AB Nov 30, 2018
300MG

tablet, extended release Prescription ORAL AB Nov 30, 2018





9. AMRING PHARMS

Amring Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Amring Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022
25MG

tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022
200MG

tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022
50MG

tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022





10. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, for suspension Prescription ORAL AB Nov 4, 2009
100MG

tablet Prescription ORAL AB Jan 27, 2009
150MG

tablet Prescription ORAL AB Jan 27, 2009
200MG

tablet Prescription ORAL AB Jan 27, 2009
5MG

tablet, for suspension Prescription ORAL AB Nov 4, 2009


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Bachupally Aurobindo Pharma Limited
Sangareddy Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
United States
East Windsor Aurobindo Pharma USA Inc





11. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Discontinued ORAL N/A Nov 1, 2010
100MG

tablet Discontinued ORAL N/A Nov 1, 2010
25MG

tablet Discontinued ORAL N/A Nov 1, 2010
200MG

tablet Discontinued ORAL N/A Nov 1, 2010





12. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, for suspension Discontinued ORAL N/A Jan 22, 2009
5MG

tablet, for suspension Discontinued ORAL N/A Jan 22, 2009





13. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 8 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, extended release Prescription ORAL AB Jun 19, 2013
5MG

tablet, for suspension Prescription ORAL AB Jan 22, 2009
100MG

tablet, extended release Prescription ORAL AB Jun 19, 2013
150MG

tablet Prescription ORAL AB Jan 27, 2009
200MG

tablet, extended release Prescription ORAL AB Jun 19, 2013
300MG

tablet, extended release Prescription ORAL AB Jun 19, 2013
50MG

tablet, extended release Prescription ORAL AB Jun 19, 2013
250MG

tablet, extended release Prescription ORAL AB Sep 6, 2018





14. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG

tablet, extended release Prescription ORAL AB Jan 18, 2013
200MG

tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015
100MG

tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015
50MG

tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015
25MG

tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015
300MG

tablet, extended release Prescription ORAL AB Jan 18, 2013





15. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB May 4, 2012
5MG

tablet, for suspension Prescription ORAL AB Feb 19, 2009
100MG

tablet Prescription ORAL AB May 4, 2012
150MG

tablet Prescription ORAL AB May 4, 2012
200MG

tablet Prescription ORAL AB May 4, 2012





16. GRANULES

Granules India Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Jan 27, 2009
100MG

tablet Discontinued ORAL N/A Jan 27, 2009
150MG

tablet Discontinued ORAL N/A Jan 27, 2009
200MG

tablet Discontinued ORAL N/A Jan 27, 2009


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Chantilly Granules Pharmaceuticals Inc.
Manassas Granules Consumer Health Inc.
India
Medchal-Malkhajgiri District Granules India Limited
Secunderabad Granules India Limited
Parawada Mandal Granules India Limited
Visakhapatnam Granules India Limited
Sangareddy District Granules India Limited





17. HIKMA PHARMS

Hikma Pharmaceuticals has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Hikma Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Discontinued ORAL N/A Apr 19, 2011
100MG

tablet Discontinued ORAL N/A Apr 19, 2011
25MG

tablet Discontinued ORAL N/A Apr 19, 2011
200MG

tablet Discontinued ORAL N/A Apr 19, 2011





18. IMPAX LABS INC

Impax Laboratories Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet, orally disintegrating Prescription ORAL AB Jul 15, 2013
200MG

tablet, orally disintegrating Prescription ORAL AB Jul 15, 2013
100MG

tablet, orally disintegrating Prescription ORAL AB Jul 15, 2013
25MG

tablet, orally disintegrating Prescription ORAL AB Jul 15, 2013





19. IPCA LABS

Ipca Laboratories Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Ipca Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Sep 26, 2024
200MG

tablet Prescription ORAL AB Sep 26, 2024
150MG

tablet Prescription ORAL AB Sep 26, 2024
25MG

tablet Prescription ORAL AB Sep 26, 2024





20. JUBILANT CADISTA

Jubilant Cadista Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Jan 27, 2009
100MG

tablet Prescription ORAL AB Jan 27, 2009
150MG

tablet Prescription ORAL AB Jan 27, 2009
200MG

tablet Prescription ORAL AB Jan 27, 2009


Manufacturing Plant Locations
New

Jubilant Cadista's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Jubilant Cadista as present at those locations.

Country City Firm Name
United States
Salisbury Jubilant Cadista Pharmaceuticals, Inc.





21. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, for suspension Discontinued ORAL N/A Feb 28, 2011
5MG

tablet, for suspension Discontinued ORAL N/A Feb 28, 2011


Manufacturing Plant Locations
New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country City Firm Name
India
Roorkee Jubilant Generics Limited





22. LUPIN LTD

Lupin Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Jun 1, 2010
100MG

tablet Prescription ORAL AB Jun 1, 2010
200MG

tablet Prescription ORAL AB Jun 1, 2010
150MG

tablet Prescription ORAL AB Jun 1, 2010


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





23. NATCO PHARMA

Natco Pharma Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Natco Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Jan 27, 2009
100MG

tablet Discontinued ORAL N/A Jan 27, 2009
150MG

tablet Discontinued ORAL N/A Jan 27, 2009
200MG

tablet Discontinued ORAL N/A Jan 27, 2009


Manufacturing Plant Locations
New

Natco Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Natco Pharma as present at those locations.

Country City Firm Name
India
Hyderabad NATCO PHARMA LTD
Rangareddy NATCO Pharma Limited
Hyderabad Natco Pharma Limited
Paravada Natco Pharma Limited
Rangareddy District Natco Pharma Ltd. - Chemical Division
Chennai NATCO Pharma Limited Chemical Division Chennai





24. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet, for suspension Discontinued ORAL N/A Jan 22, 2009
25MG

tablet Discontinued ORAL N/A Feb 11, 2009
200MG

tablet Discontinued ORAL N/A Feb 11, 2009
150MG

tablet Discontinued ORAL N/A Feb 11, 2009
100MG

tablet Discontinued ORAL N/A Feb 11, 2009





25. RISING

Rising Pharma Holding Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Jan 27, 2009
100MG

tablet Discontinued ORAL N/A Jan 27, 2009
150MG

tablet Discontinued ORAL N/A Jan 27, 2009
200MG

tablet Discontinued ORAL N/A Jan 27, 2009


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Phoenix Rising Sun Farms Inc
Livingston Risingsun Iodine Products Corp.
Rising Sun Rising Sun Veterinary Clinic
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
East Brunswick Rising Pharma Holding, Inc.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Saddle Brook Rising Pharmaceuticals, Inc.
Fort Bragg Rising Tide Sea Vegetables
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





26. ROXANE

Roxane Laboratories Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Jan 27, 2009
100MG

tablet Discontinued ORAL N/A Jan 27, 2009
150MG

tablet Discontinued ORAL N/A Jan 27, 2009
200MG

tablet Discontinued ORAL N/A Jan 27, 2009





27. RUBICON

Rubicon Research Private Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, extended release Discontinued ORAL N/A Jun 17, 2013
100MG

tablet, extended release Prescription ORAL AB Jun 17, 2013
150MG

tablet Prescription ORAL AB Jan 27, 2009
200MG

tablet, extended release Prescription ORAL AB Jun 17, 2013
50MG

tablet, extended release Discontinued ORAL N/A Jun 17, 2013


Manufacturing Plant Locations
New

Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.

Country City Firm Name
United States
Geismar Rubicon, LLC
Indianapolis Rubicon Foods LLC
Canada
Concord Rubicon Research Canada Limited
India
Ambarnath Rubicon Research Private Limited





28. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016
50MG

tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016
100MG

tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016
200MG

tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016
300MG

tablet, extended release Prescription ORAL AB Jan 4, 2013





29. TARO

Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet, for suspension Prescription ORAL AB Feb 4, 2009
25MG

tablet, for suspension Prescription ORAL AB Feb 4, 2009


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Honolulu Taro Delight, LLC
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





30. TARO PHARM INDS

Taro Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Jan 27, 2009
100MG

tablet Prescription ORAL AB Jan 27, 2009
150MG

tablet Prescription ORAL AB Jan 27, 2009
200MG

tablet Prescription ORAL AB Jan 27, 2009





31. TEVA

Teva Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet, for suspension Discontinued ORAL N/A Jun 21, 2006
25MG

tablet Discontinued ORAL N/A Aug 30, 2006
150MG

tablet Discontinued ORAL N/A Aug 30, 2006
200MG

tablet Discontinued ORAL N/A Aug 30, 2006
100MG

tablet Discontinued ORAL N/A Aug 30, 2006


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
Fort Dodge TEVA Animal Health Inc
Miami Teva Branded Pharmaceutical Products R & D, Inc.
India
Bhind Teva API India Ltd- Malanpur
Gajraula, Amroha Teva API India Private Ltd.
Canada
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Stouffville Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





32. TORRENT

Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet, extended release Discontinued ORAL N/A Dec 23, 2013
50MG

tablet, extended release Prescription ORAL AB Dec 23, 2013
100MG

tablet, extended release Prescription ORAL AB Dec 23, 2013
25MG

tablet, extended release Prescription ORAL AB Dec 23, 2013


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Bharuch Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
Pithampur Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
United States
Basking Ridge Torrent Pharma Inc.
Kalamazoo Torrent Pharma Inc.





33. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Jan 27, 2009
100MG

tablet Prescription ORAL AB Jan 27, 2009
150MG

tablet Prescription ORAL AB Jan 27, 2009
200MG

tablet Prescription ORAL AB Jan 27, 2009





34. UNICHEM LABS LTD

Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Unichem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Oct 6, 2011
150MG

tablet Prescription ORAL AB Oct 6, 2011
100MG

tablet Prescription ORAL AB Oct 6, 2011
25MG

tablet Prescription ORAL AB Oct 6, 2011





35. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, for suspension Prescription ORAL AB Jan 22, 2009
5MG

tablet, for suspension Prescription ORAL AB Jan 22, 2009
2MG

tablet, for suspension Prescription ORAL AB Jan 22, 2009





36. YILING

Yiling Pharmaceutical Ltd has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Yiling.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, extended release Prescription ORAL AB Dec 8, 2021
250MG

tablet, extended release Prescription ORAL AB Dec 8, 2021
300MG

tablet, extended release Prescription ORAL AB Dec 8, 2021
200MG

tablet, extended release Prescription ORAL AB Dec 8, 2021
100MG

tablet, extended release Prescription ORAL AB Dec 8, 2021
50MG

tablet, extended release Prescription ORAL AB Dec 8, 2021


Manufacturing Plant Locations
New

Yiling's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yiling as present at those locations.

Country City Firm Name
China
Shijiazhuang Yiling Pharmaceutical Ltd.





37. ZENNOVA

Zennova Pharmaceuticals Chengdu Co Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zennova.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Discontinued ORAL N/A Feb 4, 2009
25MG

tablet Discontinued ORAL N/A Feb 4, 2009
100MG

tablet Discontinued ORAL N/A Feb 4, 2009
200MG

tablet Discontinued ORAL N/A Feb 4, 2009





38. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet, extended release Prescription ORAL AB Apr 1, 2020
300MG

tablet, extended release Prescription ORAL AB Apr 1, 2020
25MG

tablet, extended release Prescription ORAL AB Apr 1, 2020
50MG

tablet, extended release Prescription ORAL AB Apr 1, 2020
100MG

tablet, extended release Prescription ORAL AB Apr 1, 2020
250MG

tablet, extended release Prescription ORAL AB Apr 1, 2020





39. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Jan 27, 2009
50MG

tablet Prescription ORAL N/A Jan 27, 2009
100MG

tablet Prescription ORAL AB Jan 27, 2009
150MG

tablet Prescription ORAL AB Jan 27, 2009
200MG

tablet Prescription ORAL AB Jan 27, 2009
250MG

tablet Prescription ORAL N/A Jan 27, 2009





40. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet, for suspension Prescription ORAL AB Jan 22, 2009
5MG

tablet, for suspension Prescription ORAL AB Jan 22, 2009